Literature DB >> 911611

Effect of halofenate on the serum binding of phenytoin.

F E Karch, W M Wardell, M Dambly, A Gringeri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 911611      PMCID： PMC1429162          DOI： 10.1111/j.1365-2125.1977.tb00798.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  The protein binding of some drugs in plasma from patients with alcoholic liver disease.

Authors:  M Affrime; M M Reidenberg
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

2.  The interaction between halofenate and propranolol.

Authors:  D H Huffman; D L Azarnoff; D W Shoeman; C A Dujovne
Journal:  Clin Pharmacol Ther       Date:  1976-06       Impact factor: 6.875

3.  Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

Authors:  M M Reidenberg; I Odar-Cederlöf; C von Bahr; O Borgå; F Sjöqvist
Journal:  N Engl J Med       Date:  1971-07-29       Impact factor: 91.245

4.  Effect of halofenate on binding of various drugs to human plasma proteins and on the plasma half-life of antipyrine in monkeys.

Authors:  H B Hucker; S C Stauffer; S E White
Journal:  J Pharm Sci       Date:  1972-09       Impact factor: 3.534

5.  Abnormal pharmacokinetics of phenytoin in a patient with uraemia.

Authors:  I Odar-Cederlöf; P Lunde; F Sjöqvist
Journal:  Lancet       Date:  1970-10-17       Impact factor: 79.321

6.  Studies with some novel uricosuric agents and their metabolites: correlation between clinical activity and drug-induced displacement of urate from its albumin-binding sites.

Authors:  L H Schlosstein; I Kippen; M W Whitehouse; R Bluestone; H E Paulus; J R Klinenberg
Journal:  J Lab Clin Med       Date:  1973-09

7.  Plasma protein binding of diphenylhydantoin. Effects of sex hormones, renal and hepatic disease.

Authors:  W D Hooper; F Bochner; M J Eadie; J H Tyrer
Journal:  Clin Pharmacol Ther       Date:  1974-03       Impact factor: 6.875

8.  Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy.

Authors:  N Barth; G Alván; O Borgå; F Sjöqvist
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

9.  Effect of halofenate on serum thyroid hormone determinations in vitro.

Authors:  F E Karch; J P Morgan; N P Kubasik; H E Sine
Journal:  J Clin Endocrinol Metab       Date:  1976-07       Impact factor: 5.958

10.  Effects of a new hypolipidemic agents, MK-185, on serum thyroxine-binding globulin (TBG) and dialyzable fraction thyroxine.

Authors:  P J Davis; T H Hsu; J R Bianchine; J P Morgan
Journal:  J Clin Endocrinol Metab       Date:  1972-01       Impact factor: 5.958
View more
  4 in total

Review 1.  Pharmacokinetic drug interactions with phenytoin (Part II).

Authors:  R L Nation; A M Evans; R W Milne
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

Review 2.  Drug interactions with phenytoin.

Authors:  E Perucca; A Richens
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

Review 3.  Pharmacokinetic interactions with antiepileptic drugs.

Authors:  E Perucca
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

4.  Phenytoin binding to human albumin.

Authors:  M Lecomte; R Zini; P d'Athis; J P Tillement
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.